Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • colon (1)
  • herbal (2)
  • hyperalgesia (2)
  • IBS (7)
  • IL 6 (5)
  • mucosa (3)
  • rats (9)
  • receptor par- 2 (2)
  • receptor par- 2 (2)
  • rna (2)
  • rt pcr (1)
  • sp 6 (3)
  • TNF α (5)
  • tumor necrosis factor (2)
  • Sizes of these terms reflect their relevance to your search.

    The aims of this study were to evaluate the effect and mechanism of a traditional Chinese medicine formula: Tongxieyaofang (TXYF) on Rats with Post Infectious Irritable Bowel Syndrome (PI-IBS). SD male rats in adult were used to model PI-IBS and treated with TXYF at three dosage for 14 consecutive days, and then visceral sensation and the frequency of stool in PI-IBS rats were investigated. In addition, the contents of SP, TNF- α and IL-6 in colonic mucosal were analyzed by ELISA. Moreover faecal serine protease activity and PAR-2 mRNA expression were measured by ultraviolet spectrophotometry and RT-PCR, respectively. Our study showed that TXYF attenuated visceral hyperalgesia and inhibited stool frequency in Campylobacter-stimulated Post Infectious Irritable Bowel Syndrome (PI-IBS) rats. Furthermore, TXYF decreased the colonic SP, TNF- α and IL-6 content in PI-IBS rats. In addition, the up-regulated colonic mucosa PAR-2 mRNA expression in PI-IBS rats was significantly suppressed by orally TXYF. TXYF attenuated PI-IBS symptom by attenuating behavioral hyperalgesia and anti-diarrhea, the underlying mechanism was mediated by inhibiting PAR-2 receptor expression, reducing the levels of SP, TNF- α and IL-6 in colonic mucosa and decreasing faecal serine protease activity.

    Citation

    Xuguang Hu, Xiaojun Zhang, Bin Han, Weijian Bei. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor. BMC complementary and alternative medicine. 2013 Oct 02;13:246

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 24088410

    View Full Text